Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Breast Cancer

Free Subscription 09.03.2026 2 AJR Am J Roentgenol 1 Ann Oncol 1 Ann Surg Oncol 1 Anticancer Res 2 BMC Cancer 1 Br J Cancer 1 Breast Cancer Res 1 Breast Cancer Res Treat 1 Breast J 1 Eur Radiol 1 J Biol Chem 1 J Clin Invest 1 J Clin Oncol 1 J Natl Cancer Inst 1 Nature 1 NPJ Breast Cancer 2 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. PERRY H
   Artificial Intelligence May Be a Useful Tool to Predict the Likelihood of Ipsilateral Breast Cancer Recurrence in Patients Treated for DCIS.
   AJR Am J Roentgenol. 2026 Mar 4. doi: 10.2214/AJR.26.34787.
   PubMed        
   
   
2. LAM DL, Rahbar H
   Strengthening the Case for Personalized Breast Cancer Screening Approaches.
   AJR Am J Roentgenol. 2026 Mar 4. doi: 10.2214/AJR.26.34789.
   PubMed        
   
   

   
   Ann Oncol

3. CURIGLIANO G, Hu X, Dent R, Yonemori K, et al
   Trastuzumab deruxtecan in hormone receptor-positive, HER2-low/-ultralow metastatic breast cancer (DESTINY-Breast06): outcome analyses by time to progression on prior first-line endocrine therapy with CDK4/6 inhibitor and baseline burden of disease.
   Ann Oncol. 2026 Mar 2:S0923-7534(26)00071-2. doi: 10.1016/j.annonc.2026.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

4. KLIMBERG VS
   ASO Author Reflections: Intracavitary Radiofrequency Ablation as a Means to Deescalate Radiation in Patients with Breast Cancer.
   Ann Surg Oncol. 2026 Mar 4. doi: 10.1245/s10434-026-19437.
   PubMed        
   
   

   
   Anticancer Res

5. JOHANSSON G, Kyriakogiannaki A
   Plan Quality Variability in Radiotherapy of Whole Breast and Regional Lymph Nodes: An Intra-institutional Analysis.
   Anticancer Res. 2026;46:1557-1568.
   PubMed         Abstract available
   
   

   
   BMC Cancer

6. FENG L, Liang Y, Huang J, Xu S, et al
   Evaluation of organs at risk (OARs) in whole-breast irradiation: a comparison of prone, supine position and with deep inspiration breath-hold techniques-subgroup analysis from a prospective study.
   BMC Cancer. 2026;26:307.
   PubMed         Abstract available
   
   
7. GUTIERREZ-GONZALEZ A, Maciel-Cruz EJ, Reynoso-Noveron N, Mohar-Betancourt A, et al
   Impact of germline genetic variation on breast cancer prognosis: a systematic review and meta-analysis.
   BMC Cancer. 2026 Mar 4. doi: 10.1186/s12885-026-15808.
   PubMed        
   
   

   
   Br J Cancer

8. JIANG H, Livingston M, Room R, Kibret AA, et al
   Alcohol consumption and mortality from four alcohol-related cancers in Australia 1950-2018: a time series analysis.
   Br J Cancer. 2026;134:914-923.
   PubMed         Abstract available
   
   

   
   Breast Cancer Res

9. ZOU L, Tang X, Deng P, Liu Y, et al
   Chidamide combined with fulvestrant in the treatment of HR-positive, HER2-negative advanced breast cancer after failure of previous endocrine therapy: a single-arm, single-center, phase 2 study.
   Breast Cancer Res. 2026 Mar 4. doi: 10.1186/s13058-026-02254.
   PubMed         Abstract available
   
   

   
   Breast Cancer Res Treat

10. TOLOSA P, Garcia-Fructuoso I, Pascual T, Martinez-Saez O, et al
    Real-world second- and third-line progression-free survival after progression on first-line CDK4/6 inhibitors in HR+/HER2- metastatic breast cancer by PAM50 intrinsic subtype: the SOLTI-1801 CDK-PREDICT study.
    Breast Cancer Res Treat. 2026;216:21.
    PubMed         Abstract available
    
    

    
    Breast J

11. LI J, Zhang J
    OGT-Mediated O-GlcNAcylation Stabilizes c-Myc Activity and Promotes Chemoresistance in Triple-Negative Breast Cancer.
    Breast J. 2026;2026:2120017.
    PubMed         Abstract available
    
    

    
    Eur Radiol

12. VAN DER WAAL D, Abbey CK, Tetteroo E, Geertse TD, et al
    Finding the optimal recall rate in breast cancer screening: results from the ROCS study.
    Eur Radiol. 2026 Mar 5. doi: 10.1007/s00330-026-12370.
    PubMed         Abstract available
    
    

    
    J Biol Chem

13. DOLUI B, Majumdar B, Bandyopadhyay A, Desai KV, et al
    TIM-3 inhibition enhances breast tumor progression and metastasis: A paradoxical immune checkpoint response.
    J Biol Chem. 2026;302:111096.
    PubMed         Abstract available
    
    

    
    J Clin Invest

14. ZHU XZ, Zhou YF, Ying XH, Wang YY, et al
    Comprehensive genomic profiling of triple-negative breast cancer metastases identifies role of PKD1 in immunotherapy resistance.
    J Clin Invest. 2026;136:e188989.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

15. LI T, Zhou T, Wang B, Tao Z, et al
    Phase II Clinical Study of Adebrelimab and Bevacizumab Combined With Cisplatin/Carboplatin in Patients With Triple-Negative Breast Cancer With Brain Metastases (ABC Study).
    J Clin Oncol. 2026 Mar 4:JCO2502021. doi: 10.1200/JCO-25-02021.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

16. SAMPATHKUMAR Y, Zakaria Z, O'Connell K, Bhimani J, et al
    Clinician- and facility-level factors associated with chemotherapy dose reductions in stages I-IIIA breast cancer.
    J Natl Cancer Inst. 2026 Mar 4:djag063. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Nature

17. SAFONOV A, Lee M, Brown DN, Boscolo Bielo L, et al
    Homologous recombination deficiency and hemizygosity drive resistance in breast cancer.
    Nature. 2026 Mar 4. doi: 10.1038/s41586-026-10197.
    PubMed         Abstract available
    
    

    
    NPJ Breast Cancer

18. MARRA A, Kim SH, Pareja F, Basili T, et al
    Tracking response to neoadjuvant systemic therapy through circulating tumor DNA analysis in breast cancer.
    NPJ Breast Cancer. 2026 Mar 5. doi: 10.1038/s41523-026-00921.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

19. COTTRELL O, Rowntree A, Chopra K, Mackellar E, et al
    HES1 oscillations are required for cell cycle reentry in oestrogen receptor-positive breast cancer cells.
    Proc Natl Acad Sci U S A. 2026;123:e2520724123.
    PubMed         Abstract available
    
    
20. SENTHILKUMAR I, Vangheel J, Kumar V, McNamara L, et al
    Stress-dependent growth in breast cancer arises from a mechano-osmotic coupling and cell-sizing checkpoint.
    Proc Natl Acad Sci U S A. 2026;123:e2523159123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum